Verge Genomics

United States
Wrightstown, Wisconsin, United States, 94080

Company profile

Verge Genomics company profile

Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
94080
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$134.1M
Last funding
Series Unknown / 2023-07-01
Last equity funding
Series Unknown
Investors
27
Lead investors
4
Founders
2
Articles
72

Founders and investors

Founders

Alice ZhangJason Chen

Lead investors

BlackRockIA VenturesThresholdY Combinator

Investors

Alumni VenturesBlackRockEli LillyS32Y Combinator